This Compensation Committee Charter governs the operations of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of TOMI Environmental Solutions, Inc. (the “Company”). This Charter is intended as a component of the flexible governance framework within which the Board, assisted by its committees, directs the affairs of the Company. While it should be interpreted in the context of all applicable laws, regulations and listing requirements of the NYSE MKT, as well as in the context of the Company’s Articles of Incorporation and Bylaws, it is not, subject to any contractual or other commitments of the Company, intended to establish by its own force any legally binding obligations.
The Committee shall assist the Board of Directors (the “Board”) in: (i) determining appropriate compensation levels for the Company’s executive officers; (ii) evaluating officer and director compensation plans, policies and programs; (iii) reviewing benefit plans for officers and employees; and (iv) producing the report required by applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) and other applicable regulatory bodies for inclusion in the Company’s annual proxy statement.
In addition to the powers and responsibilities expressly delegated to the Committee in this Charter, the Committee may exercise any other powers and carry out any other responsibilities delegated to it by the Board from time to time consistent with the Company’s Bylaws and applicable laws and regulations.
In discharging its role, the Committee is empowered to investigate any matter brought to its attention that is within the scope of or otherwise relevant to its responsibilities, with all requisite access to all books, records, facilities and personnel of the Company. The Committee has the power to retain, subject to concurrence of the Lead Independent Director of the Board, outside counsel or other advisors and will receive adequate funding from the Company to engage such advisors. Such counsel and/or advisors shall report directly to the Committee. The Committee shall have the requisite authority to retain, compensate, terminate and oversee executive compensation consultants.
The Committee shall consist of two or more members of the Board, each of whom is determined by the Board to be “independent” in accordance with the NYSE MKT, Marketplace Rules (except as may be allowed by those rules in exceptional circumstances) and the Company’s Corporate Governance Guidelines. In addition, no director may serve on the Committee unless he or she (i) is a “Non-employee Director” for purposes of Rule 16b-3 under the Securities Exchange Act of 1934, as amended, and (ii) satisfies the requirements of an “outside director” for purposes of Section 162(m) of the Internal Revenue Code.
The members of the Committee shall be appointed by the Board and continue to be members until their successors are elected and qualified or until their earlier resignation or removal. Any member of the Committee may be removed, with or without cause, by the Board at any time. It is expected that Committee members will rotate off the Committee, on a staggered basis, after not more than six years of service. Former committee members will be eligible to rejoin the Committee after a reasonable rotation period but, in the absence of special circumstances, it is generally expected that Committee members will not serve more than six years in any eight-year period.
The Board may appoint one member to serve as Chair of the Committee annually, to convene and chair all regular and special sessions of the Committee, set the agendas for Committee meetings and determine and communicate to management the information needs of the Committee, and to report Committee determinations and action on behalf of the Committee to the full Board. If the Board fails to appoint a Chair, the members of the Committee shall annually elect a Chair by majority vote. The Chair of the Committee shall serve as Chair for not more than six consecutive years.
The Committee shall have regular meetings on at least a semi-annual basis (or more frequently as circumstances dictate). Meetings of the Committee may be held telephonically. A majority of the members of the Committee shall constitute a quorum sufficient for the taking of any action by the Committee. The Committee shall meet separately, on at least an annual basis, with the Chief Executive Officer (the “CEO”), the vice president of human resources (or similar position) and any other corporate officers as the Board and Committee deem appropriate to discuss and review the performance criteria and compensation levels of key executives; provided, however, that the CEO shall not be present at such portion of the meeting during which the compensation of the CEO is discussed.
The Committee may form, and delegate any of its responsibilities to, a subcommittee so long as such subcommittee consists solely of at least two members of the Committee. In addition, the Equity Award Committee, as a secondary committee responsible for administering the discretionary option grant program and the stock issuance program under the Company’s current Stock Option Plan, with respect to eligible individuals other than the Company’s executive officers and Board members, shall exercise certain concurrent powers with the Committee with respect to the grant of stock options or other equity awards, as set forth in applicable resolutions of the Board.
The following functions and responsibilities are set forth as a guide for fulfilling the Committee’s purposes, with the understanding that the Committee’s activities may diverge as appropriate given the circumstances. The Committee is authorized to carry out these responsibilities, and other responsibilities assigned to it by the Board from time to time, and to take any actions reasonably related to the mandate of this Charter.
© 2024 TOMI™ Environmental Solutions, Inc | Privacy Policy
Binary Ionization Technology (BIT) is an EPA registered combination solution and application technology for use as a hospital-healthcare disinfectant and general use disinfectant (EPA registration # 90150-2). Registered in all 50 U.S. States, Canada, and International.